MindWalk's proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in MindWalk, formerly IPA, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.

Learn more